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Purpose of the study
To assess epidemiological characteristics and loss to fol-
low-up in immigrant patients, and compare them with
Spanish-born patients, in two periods: 1983–1999 and
2000–2008.
Methods
COMESEM cohort is a prospective, population-based
HIV-infected patient cohort of the south and east Greater
Madrid (Spain). To analyze "loss to follow-up" of our
patients, we collected the following data from our data-
bases: age, year of diagnosis, gender, date of the last visit,
risk group and AIDS diagnosis. We considered as "loss to
follow-up", patients who were alive in their last visit, had
not requested transfer to another medical facility and were
not registered as dead in the Mortality Registry of the
Autonomous Community of Madrid. It was also required
that at least 6 months had elapsed since their last visit.
Loss to follow-up of immigrant and Spanish-born
patients were compared by means of Kaplan-Meyer curves
(long-rank test).
Summary of results
Of 8,166 patients in our database, 5,450 were amenable
to analysis (852 were immigrants). Since there were statis-
tically significant differences in the percentage of immi-
grant patients between both time periods (3.8% vs.
43.5%, p = 0.0001), we carried out the analysis by strati-
fying into the periods. There were no significant differ-
ences in age between time periods. In immigrant patients:
the percentage of women increased in the second period
(40% vs. 52%, p = 0.0003), so did the sexual transmission
risk group (67.6% vs. 90.3%), and AIDS diagnoses in this
population diminished (37.4% vs. 24.7%, p = 0,0001).
Although there was statistically significant more "loss to
follow-up" of immigrants than Spanish-born patients in
the second period (p = 0.0004), this difference does not
seem clinically important (11.9% in immigrant vs. 7.12%
in Spanish-born patients).
Conclusion
1. In the last 8 years, around 50% of new diagnoses of HIV
infection have been established in immigrant patients. 2.
The frequency in immigrant patients has increased in
women and in the sexually transmitted risk group. 3.
AIDS diagnoses in this population have diminished in
later years. 4. Although we observed differences in "loss to
follow-up" between immigrants and Spanish-born
patients, these do not seem very relevant. A likely explana-
tion is the universal access to medical care in Spain, and
particularly HIV treatment, which is also assured for
immigrant patients.
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